[Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL+ leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE